Published in Medical Imaging Business Week, June 23rd, 2005
"The aim was to evaluate the efficacy of FDG-PET in early discrimination of response to definitive radiotherapy (RT) in patients with squamous cell carcinoma of the head and neck (SCCHN). Twenty-four patients who underwent FDG-PET scans before and after radiotherapy for nondisseminated SCCHN at the Asian Medical Center between August 2001 and September 2002 were prospectively evaluated," investigators in South Korea reported.
"Initial FDG-PET scans were performed within 1 month before RT, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.